Slow recovery of conduction velocity from use dependent inhibition induced by quinidine in guinea pig ventricular myocardium. 1991

J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
Department of Internal Medicine, Tottori University School of Medicine, Yonago, Japan.

OBJECTIVE The aim was to investigate whether the use dependent effects of antiarrhythmic drugs on the Na+ current could be applied to explain their effects on impulse conduction. METHODS Trains of rapid stimuli were applied to guinea pig papillary muscles via an electrode in the presence of quinidine (20 and 60 mumol.litre-1), and the conduction velocity was determined from the time difference between two signals of the maximal rate of rise (dV/dtmax) of the action potentials at two separate sites. The relationship of the time constants of the onset and recovery from the use dependent inhibition induced by quinidine was determined for the dV/dtmax and the conduction velocity. METHODS Six male Hartley guinea pigs weighing 200 to 300 g were killed by a blow to the head and the papillary muscles were rapidly excised from the right ventricles. The preparations were superfused with Tyrode solution. RESULTS The rate of onset of the use dependent inhibition of conduction velocity and that of the square of conduction velocity were both faster than the simultaneously measured rate of onset of dV/dtmax inhibition induced by 20 mumol.litre-1 quinidine at high frequency stimulation. The relation between the rates of onset of the use dependent inhibition of conduction velocity (and the square of conduction velocity) and dV/dtmax became weak with low frequency stimulation and in the presence of 60 mumol.litre-1 quinidine. However, the recovery of conduction velocity (and the square of conduction velocity) from quinidine induced use dependent blockade, as measured by the extrastimulation method, appeared to be slower than the recovery of dV/dtmax. These results may be explained by a transient change in intracellular and intercellular conditions, such as an increase in internal resistance. CONCLUSIONS The onset and recovery of the use dependent inhibition of conduction by antiarrhythmic drug may not always parallel the changes of the dV/dtmax of action potential in multicellular muscle preparations.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
May 1993, Journal of clinical pharmacology,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
December 1990, European journal of pharmacology,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
April 1990, British journal of pharmacology,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
November 1998, Experimental physiology,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
September 2002, Clinical and experimental pharmacology & physiology,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
October 1984, The American journal of physiology,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
February 1982, Circulation research,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
January 1980, Naunyn-Schmiedeberg's archives of pharmacology,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
February 1976, The Journal of pharmacology and experimental therapeutics,
J Hasegawa, and T Nawada, and S Hirai, and Y Kurata, and K Ogino, and H Kotake, and H Mashiba
January 1982, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!